GeneTex
  • Country / Location Selection

United States (US)

KAP1 blocking peptide

Cat No. GTX31274-PEP

Application

Neutralizing/Inhibition
Package
50 μg ($139)
PRODUCT

Summary

KAP1 peptide is used for blocking the activity of KAP1 antibody (catalog number GTX31274).

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl), 0.1% BSA, 0.02% sodium azide

Storage

Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Concentration

200 μg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

TARGET

Synonyms

Tripartite Motif Containing 28 , Kap1 , Ppp1R157 , Rnf96 , Tf1B , Tif1B , Trim28

Background

The protein encoded by this gene mediates transcriptional control by interaction with the Kruppel-associated box repression domain found in many transcription factors. The protein localizes to the nucleus and is thought to associate with specific chromatin regions. The protein is a member of the tripartite motif family. This tripartite motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. [provided by RefSeq, Jul 2008]

Research Area

REFERENCE

There are currently no references for KAP1 blocking peptide (GTX31274-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for KAP1 blocking peptide (GTX31274-PEP). Be the first to share your experience with this product.
SDS
PBS.pdf
Sodium Azide.pdf